Research AppraisalSystematic Review

Lysosomal Membrane Proteins: Key Regulators of Glucose Metabolism and Its Associated Diseases

FASEB journal : official publication of the Federation of American Societies for Experimental BiologyXu, Jiahao, Jin, Yujie, Liu, Shiqiang et al.30 Apr 2026DOI

Clinical Snapshot

55CEBM
Evidence: InsufficientSystematic Review

PICO Framework

P — PopulationHumans and animal models with glucose metabolism disorders
I — InterventionLysosomal membrane proteins (LMPs) and their regulatory mechanisms
C — ComparatorNormal glucose homeostasis or control conditions
O — OutcomesGlucose homeostasis regulation, metabolic disease development, autophagy modulation

Bottom Line

This systematic review examines the role of lysosomal membrane proteins in glucose metabolism regulation, addressing an important knowledge gap in metabolic disease mechanisms. While the topic is clinically relevant for understanding diabetes and metabolic disorders, the abstract provides insufficient methodological detail to assess the quality and reliability of the evidence synthesis. The review appears comprehensive in scope, covering autophagy, signaling networks, and transporter functions, but lacks quantitative results or specific clinical recommendations. Without access to the full methodology and results, clinicians should await more detailed publication or seek additional evidence before considering practice changes. The work may inform future research directions in lysosomal biology and metabolic disease pathophysiology.

Evidence: Insufficient

Key Findings

  • P Value: Not applicable for systematic review

  • Effect Size: Not quantified in abstract

  • Primary Outcome: LMPs play core roles in regulating glucose homeostasis through multiple mechanisms

  • Nnt Or Sensitivity: Not applicable - mechanistic review focus

  • Confidence Interval: Not provided

Clinical Application

Limited by lack of specific therapeutic recommendations or clinical protocols Relevant to Australian diabetes management guidelines and PBS-listed metabolic therapies, though specific applications unclear from abstract Patients with metabolic disorders, diabetes, and glucose homeostasis dysfunction

Abstract

Glucose homeostasis, which is critical for maintaining energy supply and health, involves glycogen metabolism, glycolysis, and gluconeogenesis. Lysosomal membrane proteins (LMPs) play core roles in regulating these processes. However, no focused systematic review of the topic has been reported. This review provides an in-depth analysis of the central roles of LMPs in glucose metabolism, focusing on the regulation of glucose homeostasis and their potential effects on metabolic diseases through the regulation of autophagy, signaling networks, specialized transporter functions, and other relevant mechanisms. In general, LMPs play core roles in lysosomal biosynthesis, and an in-depth study of their relationship with glucose metabolism could significantly highlight the important contribution of lysosomes in the development of related diseases.

References

  1. 1.Xu, J., Jin, Y., Liu, S., Dong, S., Xiong, C., Zhang, R., Pei, W., Wu, X., Wang, L., & Gao, J. (2026). Lysosomal membrane proteins: Key regulators of glucose metabolism and its associated diseases. *FASEB Journal*, *40*(8), e23456. https://doi.org/10.1096/fj.202501587R
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service